0
Editor's Correspondence |

High-Dose PPIs in Patients With Variceal Hemorrhage

Cesar Alaniz, PharmD; Rima A. Mohammad, PharmD; Lynda S. Welage, PharmD, BCPS
Arch Intern Med. 2010;170(18):1698. doi:10.1001/archinternmed.2010.358.
Text Size: A A A
Published online

Extract

The meta-analysis by Wang et al1 shows no additional benefit in reducing the rates of rebleeding, surgical intervention, or mortality with the use of high-dose PPIs compared with non–high-dose PPIs for the treatment of patients with bleeding peptic ulcers. We would like to comment on another clinical condition in which we have seen increased use of high-dose PPIs: acute variceal hemorrhage. To our knowledge, there are no prospective studies that have evaluated use of high-dose PPIs in this setting. We previously conducted a retrospective cohort study to assess the effect of high-dose PPIs (defined as >24 hours continuous infusion of pantoprazole) on patient outcomes.2 We compared patients using high-dose PPIs with patients using non–high-dose PPIs (defined as ≤24 hours of infusion of pantoprazole or intermittent acid suppression). Both groups received standard octreotide therapy for the treatment of variceal hemorrhage. Both groups were similar at baseline with respect to Child-Pugh score, international normalized ratios, Acute Physiology and Chronic Health Evaluation (APACHE) III score, and hemoglobin concentration. The mean (SD) duration of high-dose PPI was 63.3 (48.9) hours (range, 25-332 hours). Results showed no difference in outcome with respect to transfusion of packed red blood cells or platelets. Curiously, the high-dose PPI group received more units of fresh-frozen plasma throughout the hospital stay compared with the non–high-dose PPI group (mean [SD], 6.1 [10.6] U vs 2.9 [6.2] U; P = .05). Furthermore, there was an increased rate of rebleeding in the high-dose PPI group, although this was nonsignificant (13% vs 5%; P = .12). Although differences observed may theoretically be attributed to differences in the 2 groups owing to the retrospective nature of the study, it is interesting that Wang et al1 also observed an increased rate of rebleeding in the high-dose PPI group compared with the non–high-dose group (12.3% vs 10.2%; odds ratio, 1.3 [95% confidence interval, 0.88-1.91]). Overall, the results of our study extend the findings of Wang et al and suggest that use of high-dose PPI therapy does not confer additional benefit in the management of variceal hemorrhage.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();